Schedule 13G ownership disclosure

BIOSTEM TECHNOLOGIES INC

Common Stock, $0.001 par value (the "Common Stock") · CUSIP: 090684200

Event date: 2026-09-30

Filing-level shares
3,665,899.00
Percent of class
17.4%
  • Jason Matuszewski

    Shares: 3,665,899.00 · Class: 17.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-26-118035
Form type
SCHEDULE 13G
Filer
BioStem Technologies, Inc.
CIK
CIK 1658678
Filed
Nov 10, 2026
Reporting period
Sep 30, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub